跳至主要内容
临床试验/NCT05962112
NCT05962112招募中不适用

Metabolic Implications of Day and Night-shift Working on NHS Healthcare Staff

University of Oxford1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
15
试验地点
1
主要终点
Change in percentage incorporation of 2H2 palmitate from 2H2O into very low density lipoprotein triglyceride (VLDL-TG) after night shifts compared to day-shifts

研究概览

简要总结

The investigators will conduct an open label, experimental medicine study exploring the acute metabolic impact of night-shift compared to day-shift work in NHS healthcare workers. Employees who are scheduled to work both day and night shifts will be recruited and identical metabolic investigations will be performed in the same participant following at least 3 consecutive day and night-shifts respectively. These investigations will take place at the Clinical Research Unit (CRU) in Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) at Churchill Hospital. The order of post-day and post-night shift investigations will be randomly determined and there will be a 2-week minimum interval between both sets of investigations. Participants will complete a self-reported food diary before and during each set of shifts (both day and night) and will have wrist-watch actigraphy performed throughout the entire study period in order to measure sleep and activity parameters. All study visits and investigations will commence at the CRU at 8am and will include a 2-step hyperinsulinaemic euglycaemic clamp with stable isotope infusions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • National Health Service (NHS) worker with rotating night and day shift working patterns
  • Age 18-75 years

排除标准

  • A diagnosis of type 1 or type 2 diabetes
  • Pregnancy
  • A blood haemoglobin <120mg/dL
  • History of alcohol use disorder or a greater than recommended alcohol intake (Recommendations > 21 units on average per week for men and > 14 units on average per week for women)
  • Other conditions or co-morbidities that in the eyes of the investigators may affect data collection
  • Any condition in the opinion of the investigator that might impact upon safety or validity of the results
  • Primary sleep disorder
  • Current glucocorticoid use
  • Current melatonin use
  • Patients with known non-alcoholic steatohepatitis or advanced hepatic fibrosis/cirrhosis

结局指标

主要结局

Change in percentage incorporation of 2H2 palmitate from 2H2O into very low density lipoprotein triglyceride (VLDL-TG) after night shifts compared to day-shifts

时间窗: Through study completion (average of 2 weeks)

Incorporation of 2H2 palmitate from 2H2O into very low density lipoprotein triglyceride (VLDL-TG) represents a marker of hepatic de novo lipogenesis

次要结局

  • Change in hepatic and peripheral insulin sensitivity (measured by glucose metabolism during hyperinsulinaemic euglycaemic clamp procedure) after night shifts compared to day shifts(Through study completion (average of 2 weeks))
  • Mean daily sleep onset, wake time, midpoint of sleep, and sleep efficiency(Through study completion (average of 2 weeks))
  • Mean daily activity counts(Through study completion (average of 2 weeks))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验